Quarterly Result28 Jan 2026, 03:16 pm
Acutaas Chemicals Q3 FY26 Results: Revenue at INR 3,932mn, PAT Crosses INR 1,000mn
AI Summary
Acutaas Chemicals Limited, a leading global manufacturer of advance pharmaceutical intermediates and speciality chemicals, has reported financial results for the quarter and nine months ended December 31, 2025. The company's Q3 FY26 revenue from operations stood at INR 3,932mn, up 43.0% YoY. The PAT for the quarter crossed the INR 1,000mn milestone, reaching INR 1,062mn, up 133.7% YoY. The company's gross margin improved to 57.0% in Q3 FY26, up 1,073 bps YoY. EBITDA for the quarter came at INR 1,507mn, up 119.4% YoY.
Key Highlights
- Q3FY26 Revenue from Operations at INR 3,932mn, up 43.0% YoY
- Q3 FY26 PAT crosses INR 1,000mn milestone, reaching INR 1,062mn, up 133.7% YoY
- Gross margin for Q3 FY26 improved to 57.0%, up 1,073 bps YoY
- EBITDA for Q3 FY26 came at INR 1,507mn, up 119.4% YoY
- Company expects each vertical to operate as an independent, self-sustaining growth engine, contributing meaningfully to the overall topline over the next three years